Bishara Jihad, Goldberg Elad, Madar-Shapiro Liora, Behor Jaqueline, Samra Zmira
Infectious Diseases Unit, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.
Isr Med Assoc J. 2011 Jun;13(6):338-41.
The rate of infection with Clostridium difficile colitis and its associated mortality have been increasing in the last decade. The molecular epidemiology of C. difficile in Israel has not been studied.
To screen for the existence of the 027 and 078 ribotypes and determine the longitudinal molecular epidemiology of the circulating clinical C. difficile isolates in a large hospital in central Israel.
Polymerase chain reaction (PCR) ribotyping was performed on C. difficile isolates obtained from hospitalized patients from November 2003 to May 2004 (first study period) and September 2009 (second study period). Isolates with PCR ribotype patterns, unlike those of the available reference strains (078 and 027), were labeled with letters. Forty-six isolates from the first study period and 20 from the second were analyzed.
PCR strain typing of C. difficile isolates yielded approximately 26 unique ribotypes. During the first study period, ribotype A and B accounted for 30% and 28%, respectively, whereas ribotype E and K accounted for 6.5% for each. During the second study period, ribotypes A, E and K disappeared, and the incidence of ribotype B decreased from 28% to 15%. One isolate (1/20, 5%) emerged during the second period and was identified as ribotype 027. Moxifloxacin resistance was found in 93% of ribotype A isolates, 81% of the ribotype B group, and in 44% of other ribotypes.
The predominant ribotypes circulating in our institution were diverse and changing. This is the first report on the emergence of the 027 ribotype in Israel.
在过去十年中,艰难梭菌结肠炎的感染率及其相关死亡率一直在上升。以色列艰难梭菌的分子流行病学尚未得到研究。
筛查027和078核糖体分型的存在情况,并确定以色列中部一家大型医院中循环临床艰难梭菌分离株的纵向分子流行病学。
对2003年11月至2004年5月(第一个研究期)和2009年9月(第二个研究期)从住院患者中获得的艰难梭菌分离株进行聚合酶链反应(PCR)核糖体分型。与可用参考菌株(078和027)不同的PCR核糖体分型模式的分离株用字母标记。分析了第一个研究期的46株分离株和第二个研究期的20株分离株。
艰难梭菌分离株的PCR菌株分型产生了约26种独特的核糖体分型。在第一个研究期,核糖体分型A和B分别占30%和28%,而核糖体分型E和K各占6.5%。在第二个研究期,核糖体分型A、E和K消失,核糖体分型B的发生率从28%降至15%。在第二个时期出现了一株分离株(1/20,5%),被鉴定为核糖体分型027。在93%的核糖体分型A分离株、81%的核糖体分型B组分离株和44%的其他核糖体分型分离株中发现了莫西沙星耐药性。
在我们机构中传播的主要核糖体分型多种多样且不断变化。这是以色列关于027核糖体分型出现的首次报告。